Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
New MS blood test to launch in Europe
Siemens Healthineers has received CE Mark approval for its test for the management of relapsing multiple sclerosis, allowing it to be launched in Europe.
Read more
UK generics body wants in on VPAS talks
The BGMA has launched legal action over the decision to only grant it ‘observer’ status in the upcoming VPAS negotiations. Read more.
Spotlight: January-April 2023
GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering landmark therapy approvals, insulin price cuts and much more.
Eli Lilly improves cold chain capacity
Eli Lilly has pledged over $1m to improve cold chain capacity for insulin in low- to middle-income countries.
Pharma voted second most trusted industry in Britain
The pharmaceutical industry is the second most trusted sector in Great Britain, according to the latest Ipsos Trustworthiness Index.
Moderna becomes latest ABPI member
Moderna has become the latest member of the ABPI as part of its long-term commitment to expand in the UK.
HBA names 2023 Woman of the Year
The HBA has named its 2023 Woman of the Year, Honourable Mentor and STAR volunteer leader.
ROI in R&D declines sharply in 2022
Projected pharmaceutical R&D return on investment has hit its lowest level for 13 years, according to a new report by Deloitte.
Spotlight: December 2022 - January 2023
GOLD looks back at some of the pharma industry’s recent news.
Loading posts...
« Previous
1
2
3
4
5
6
…
9
Next »